Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms: SPAP1C, SPAP1B, SPAP1A, SPAP1, IRTA4, IFGP4, FCRL2, FCRH2, Fc receptor like 2, CD307b


| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 5 µg | $59 | 7-10 days | 7-10 days | |
| 10 µg | $95 | 7-10 days | 7-10 days | |
| 20 µg | $155 | 7-10 days | 7-10 days | |
| 50 µg | $296 | 7-10 days | 7-10 days | |
| 100 µg | $497 | 7-10 days | 7-10 days | |
| 200 µg | $987 | 7-10 days | 7-10 days |
| Bioactivity | Activity testing is in progress. It is theoretically active, but we cannot guarantee it. If you require protein activity, we recommend choosing the eukaryotic expression version first. |
| Description | Fc receptor-like 2 (FCRL2) is highly expressed on B-cell chronic lymphocytic leukemia (B-CLL) cells and could possibly influence disease pathogenesis. FCRL2 has robust predictive value for determining IGHV gene mutation status and clinical progression and thus may further improve prognostic definition in CLL (B-cell chronic lymphocytic leukemia). |
| Species | Human |
| Expression System | HEK293 Cells |
| Tag | C-His |
| Accession Number | Q96LA5-1 |
| Construction | A DNA sequence encoding the human FCRL2 (NP_110391.2) (Met1-Asp395) was expressed with a polyhistidine tag at the C-terminus. Predicted N terminal: Leu 20 |
| Protein Purity | > 90 % as determined by SDS-PAGE. |
| Endotoxin | < 1.0 EU/μg of the protein as determined by the LAL method. |
| Formulation | Lyophilized from a solution filtered through a 0.22 μm filter, containing PBS, pH 7.4. Typically, a mixture containing 5% to 8% trehalose, mannitol, and 0.01% Tween 80 is incorporated as a protective agent before lyophilization. |
| Reconstitution | A Certificate of Analysis (CoA) containing reconstitution instructions is included with the products. Please refer to the CoA for detailed information. |
| Synonyms | SPAP1C, SPAP1B, SPAP1A, SPAP1, IRTA4, IFGP4, FCRL2, FCRH2, Fc receptor like 2, CD307b |
| Research Background | Fc receptor-like 2 (FCRL2) is highly expressed on B-cell chronic lymphocytic leukemia (B-CLL) cells and could possibly influence disease pathogenesis. FCRL2 has robust predictive value for determining IGHV gene mutation status and clinical progression and thus may further improve prognostic definition in CLL (B-cell chronic lymphocytic leukemia). |
| Molecular Weight | 42.5 kDa (predicted) |
| Shipping | In general, lyophilized powders are shipped with blue ice, while solutions are shipped with dry ice. |
| Storage | It is recommended to store recombinant proteins at -20°C to -80°C for future use. Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.